RT @ericdeinmd: Year in Review #ACR22 Pegloticase and MTX now FDA approved co-administration for tophaceous gout to prev
Tweet Content
Year in Review
#ACR22
Pegloticase and MTX now FDA approved co-administration for tophaceous gout to prevent anti-drug antibodies
@RheumNow https://t.co/EPtOrjJqLd
Show on Archive Page
On
Display in Search Results
On
PDQ
Off